Skip to main content
COGNITION THERAPEUTICS INC logo

COGNITION THERAPEUTICS INC — Investor Relations & Filings

Ticker · CGTX ISIN · US19243B1026 US Professional, scientific and technical activities
Filings indexed 280 across all filing types
Latest filing 2026-05-08 Interim / Quarterly Rep…
Country US United States of America
Listing US CGTX

About COGNITION THERAPEUTICS INC

https://cogrx.com/

Cognition Therapeutics, Inc. is a clinical-stage neuroscience company that discovers and develops oral, small-molecule therapeutics for neurodegenerative disorders. The company's primary focus is on conditions such as Alzheimer's disease and Dementia with Lewy Bodies (DLB). Its therapeutic approach is centered on developing medications designed to target and modulate key cellular damage response mechanisms. By aiming to rescue trafficking deficits and restore normal cellular housekeeping functions, the company seeks to protect neurons, improve synaptic health, and ultimately address the cognitive decline associated with these diseases.

Recent filings

Filing Released Lang Actions
10-Q - COGNITION THERAPEUTICS INC (0001455365) (Filer)
Interim / Quarterly Report
2026-05-08 English
S-8 - COGNITION THERAPEUTICS INC (0001455365) (Filer)
Registration Form
2026-03-26 English
10-K - COGNITION THERAPEUTICS INC (0001455365) (Filer)
Annual Report FY 2025
2026-03-26 English
8-K - COGNITION THERAPEUTICS INC (0001455365) (Filer)
Regulatory Filings
2026-03-26 English
8-K - COGNITION THERAPEUTICS INC (0001455365) (Filer)
Regulatory Filings
2026-03-02 English
4 - COGNITION THERAPEUTICS INC (0001455365) (Filer)
Director's Dealing
2026-02-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.